Deadline for responses to the consultation: 9 May 2010.
European Executive Agency for Health and Consumers calls for proposals. Submission deadline: March 19, 2010
Job vacancies in Hepatology
EU Funding

The European Union (EU) has established funding programmes in the areas of research and public health which are applicable and potentially supportive of EASL's work.

We thank our Premium Sponsors for their generous contributions and support of the EU Framework project application support programme.

Bristol Myers Squibb logo Gilead Merck logo Roche logo

1. EU Research Framework Programme (FP)

The EU's main instrument to support EU’s research is the Seventh Research Framework Programme (FP7) (2007-2013) which has allocated a budget of over €6 billion to health only. Unfortunately, liver disease remains absent from the overall FP7’s health priorities.This is why EASL has been pushing for the inclusion of calls for proposal related to liver disease within the different streams of FP7’s priorities, e.g. within cancer, chronic diseases and rare diseases. EASL has also developed the EU Framework Programme Application Support Programme to support your projects during the application process of an FP7 call.

2. EU Public Health Action Programme (PHAP)

The EU has adopted its Second Public Health Programme (2008-2013), whose annual programme is implemented by the Executive Agency for Health and Consumers (EAHC) with the annual publication of calls for proposal. Although, the programme fails to specifically prioritise ‘liver disease’, EASL has successfully been making the case for the inclusion of calls for proposal in relation to liver disease within the other priorities (.e.g., EASL 2008 response to the European Commission open consultation on health priorities).